Alexandria Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-80
Closed -$11K – 285
2017
Q3
$11K Buy
80
+11
+16% +$1.39K ﹤0.01% 402
2017
Q2
$9K Buy
+69
New +$8.25K ﹤0.01% 425
2015
Q4
– Sell
-100
Closed -$9K – 649
2015
Q3
$9K Hold
100
– – ﹤0.01% 418
2015
Q2
$9K Hold
100
– – ﹤0.01% 428
2015
Q1
$9K Hold
100
– – ﹤0.01% 408
2014
Q4
$9K Hold
100
– – ﹤0.01% 374
2014
Q3
$8K Hold
100
– – ﹤0.01% 370
2014
Q2
$7K Sell
100
-33
-25% -$2.32K ﹤0.01% 396
2014
Q1
$10K Sell
133
-1
-0.7% -$75 ﹤0.01% 357
2013
Q4
$11K Buy
134
+22
+20% +$1.72K ﹤0.01% 347
2013
Q3
$8K Buy
112
+12
+12% +$884 ﹤0.01% 385
2013
Q2
$8K Buy
+100
New +$6.56K ﹤0.01% 402

Other funds holding CME

Alexandria Capital's CME Position: Q4 2017 in Review

Alexandria Capital sold out of CME Group (CME) in Q4 2017, closing a stake of 80 shares — an estimated $11K sold.

Alexandria Capital first reported a position in CME in Q2 2013 and held it in 12 quarters. The position peaked at $11K in Q3 2017. 857 funds tracked by Wall St. Rank hold CME as of Q4 2017.

  • Alexandria Capital reported no remaining CME Group position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 80 CME Group shares in Q4 2017, an estimated $11K.
  • Alexandria Capital first reported a position in CME Group in Q2 2013 and held it in 12 quarters.
  • Alexandria Capital's CME Group position peaked at $11K in Q3 2017.
  • 857 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.